These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 37696680)

  • 21. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis.
    Nakamoto N; Sasaki N; Aoki R; Miyamoto K; Suda W; Teratani T; Suzuki T; Koda Y; Chu PS; Taniki N; Yamaguchi A; Kanamori M; Kamada N; Hattori M; Ashida H; Sakamoto M; Atarashi K; Narushima S; Yoshimura A; Honda K; Sato T; Kanai T
    Nat Microbiol; 2019 Mar; 4(3):492-503. PubMed ID: 30643240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
    Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
    J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of ulcerative colitis on liver-related outcomes of children with primary sclerosing cholangitis.
    Sathiaseelan M; Bolia R; Barallon R; Alex G; Hardikar W; Rajanayagam J
    J Paediatr Child Health; 2022 Jul; 58(7):1221-1227. PubMed ID: 35373867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.
    de Krijger M; Hageman IL; Li Yim AYF; Verhoeff J; Garcia Vallejo JJ; van Hamersveld PHP; Levin E; Hakvoort TBM; Wildenberg ME; Henneman P; Ponsioen CY; de Jonge WJ
    Front Immunol; 2022; 13():840935. PubMed ID: 35371111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.
    Coufal S; Galanova N; Bajer L; Gajdarova Z; Schierova D; Jiraskova Zakostelska Z; Kostovcikova K; Jackova Z; Stehlikova Z; Drastich P; Tlaskalova-Hogenova H; Kverka M
    Cells; 2019 Jul; 8(7):. PubMed ID: 31337064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?
    Shah A; Pakneeshan S; Jones MP; Koloski N; Callaghan G; Morrison M; Holtmann G
    Indian J Gastroenterol; 2022 Oct; 41(5):519-524. PubMed ID: 36217097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Natural History of Newly Diagnosed Ulcerative Colitis in Patients with Concomitant Primary Sclerosing Cholangitis.
    Khan N; Trivedi C; Shah Y; Cole E; Lewis J; Yang YX
    Inflamm Bowel Dis; 2018 Aug; 24(9):2062-2067. PubMed ID: 29697792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course of primary sclerosing cholangitis and concomitant ulcerative colitis - a preliminary report of retrospective study among patients from Southern Poland.
    Głowacki MK; Zwolińska-Wcisło M; Frączek P; Gomulska M; Owczarek D; Cibor D; Cieśla A; Mach T
    Folia Med Cracov; 2015; 55(2):61-8. PubMed ID: 26839244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?
    Tanaka A; Mertens JC
    Inflamm Intest Dis; 2016 Apr; 1(1):9-14. PubMed ID: 29922654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
    Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY
    Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique Inflammatory Bowel Disease Phenotype of Pediatric Primary Sclerosing Cholangitis: A Single-Center Study.
    Shiau H; Ihekweazu FD; Amin M; Fofanova T; Miloh T; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):404-409. PubMed ID: 28141677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
    Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
    Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
    Culver EL; Bungay HK; Betts M; Forde C; Buchel O; Manganis C; Warren BF; Cummings FR; Keshav S; Travis SPL; Chapman RW
    Liver Int; 2020 Nov; 40(11):2744-2757. PubMed ID: 32841490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
    Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis.
    Lampinen M; Fredricsson A; Vessby J; Martinez JF; Wanders A; Rorsman F; Carlson M
    J Leukoc Biol; 2018 Jul; 104(1):173-183. PubMed ID: 29603385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
    Hole MJ; Jørgensen KK; Holm K; Braadland PR; Meyer-Myklestad MH; Medhus AW; Reikvam DH; Götz A; Grzyb K; Boberg KM; Karlsen TH; Kummen M; Hov JR
    Hepatology; 2023 Mar; 77(3):715-728. PubMed ID: 36056902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
    Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
    World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
    Maldonado-Arriaga B; Sandoval-Jiménez S; Rodríguez-Silverio J; Lizeth Alcaráz-Estrada S; Cortés-Espinosa T; Pérez-Cabeza de Vaca R; Licona-Cassani C; Gámez-Valdez JS; Shaw J; Mondragón-Terán P; Hernández-Cortez C; Suárez-Cuenca JA; Castro-Escarpulli G
    Microbiologyopen; 2021 Mar; 10(2):e1181. PubMed ID: 33970546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.